http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100457351-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100457351-B1 |
| titleOfInvention | Uses of IgE-dependent histamine-releasing factor(HRF) and peptides binding thereto |
| abstract | The present invention relates to the use of HRF binding peptides for the induction and inhibition of neurotransmitter release of IgE-dependent histamine-releasing factor (HRF), For example, it can be usefully used as a diagnostic, prophylactic or therapeutic agent for stroke, Alzheimer's disease or Parkinson's disease. |
| priorityDate | 2001-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.